FY2026 EPS Estimates for REGENXBIO Lowered by Analyst
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Equities researchers at Chardan Capital decreased their FY2026 earnings per share estimates for REGENXBIO in a report released on Wednesday, May 14th. Chardan Capital analyst D. Gataulin now anticipates that the biotechnology company will earn $4.51 per share for the year, down from their prior forecast of $4.87. […]
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Equities researchers at Chardan Capital decreased their FY2026 earnings per share estimates for REGENXBIO in a report released on Wednesday, May 14th. Chardan Capital analyst D. Gataulin now anticipates that the biotechnology company will earn $4.51 per share for the year, down from their prior forecast of $4.87. […]
